Welcome to our dedicated page for Allient news (Ticker: $ALNT), a resource for investors and traders seeking the latest updates and insights on Allient stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Allient's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Allient's position in the market.
Allient Inc. (ALNT) reported a first-quarter revenue of $146.7 million, showing a 1% increase over the prior year. The company experienced an 80 basis points expansion in gross margin and a 6% increase in operating income to $12.1 million. Net income per diluted share rose by 8% to $0.42. Adjusted net income per share reached $0.58, indicating a 5% growth. Allient generated $9.2 million in cash from operations, more than double the previous year's first quarter. The company's strategic actions for 2024 include footprint rationalization, simplification of customer interactions, and product development timeline reduction.
Allient Inc. (Nasdaq: ALNT) declared a quarterly cash dividend of $0.03 per share. The dividend payment is scheduled for June 6, 2024, to stockholders of record as of May 23, 2024.